IDEAS home Printed from
MyIDEAS: Log in (now much improved!) to save this article

Brevets et accès aux médicaments dans les pays en développement

Listed author(s):
  • Emmanuel Combe
  • Etienne Pfister
Registered author(s):

    [eng] Patent and Drugs in Developing Countries. This article surveys the empirical literature on how patents affect access to drugs in developing countries. In the short run, higher prices and lower access rates are very likely, notably for those countries that benefited from a competitive supply before the TRIPS agreement came into force. The increase in prices can be mitigated if the pharmaceutical firms take into account the low revenues of their patients, which is more probable if external pricing and parallel imports are banned. The importing states can also bargain down the prices, thanks to price controls, compulsory licensing and grouped procurement. The effect of patent protection in the long run remains more uncertain, but the incentives to innovate are likely to be only marginally influenced by the added patent protection, mainly because of the sheer poverty of the countries where patent protection has been introduced.

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

    File URL:
    Download Restriction: no

    File URL:
    Download Restriction: no

    Article provided by Programme National Persée in its journal Revue française d'économie.

    Volume (Year): 19 (2004)
    Issue (Month): 2 ()
    Pages: 89-119

    in new window

    Handle: RePEc:prs:rfreco:rfeco_0769-0479_2004_num_19_2_1548
    Note: DOI:10.3406/rfeco.2004.1548
    Contact details of provider: Web page:

    No references listed on IDEAS
    You can help add them by filling out this form.

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    When requesting a correction, please mention this item's handle: RePEc:prs:rfreco:rfeco_0769-0479_2004_num_19_2_1548. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Equipe PERSEE)

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.